Founder Victoria Jackson shares her lifelong experiences with Jay Shetty on the “On Purpose” podcast. Listen Now
See Montel Williams and Victoria Jackson host the incredible story of GJCF. Watch Now
A Mediaplanet Guide to Rare Diseases. This campaign was distributed with USA Today newspaper and launched on futureofpersonalhealth.com Click here to learn more.
In this dynamic episode, Meghan explores the origin and plague of “the B word” and its cousin “difficult” and how these terms are often wrongly…
WALTHAM, Mass. and BEVERLY HILLS, Calif., March 30, 2021 /PRNewswire/ — CorEvitas and The Guthy-Jackson Charitable Foundation (GJCF) are excited to announce plans for launching the SPHERES (Synergy of Prospective Health & Experimental Research…
Learn about the four main advocacy groups in NMOSD, and their incredible origin stories. Click here to view the full article.
Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS)… Click here…
September 12, 2019 | Beverly Hills, CA — Genentech, a member of the Roche Group, announced positive results from one of its phase III clinical…
The 46-year-old woman suddenly felt too weak to stand. She slowly lowered herself to her kitchen floor. She’d been vomiting for the past five weeks,…
KCBS Radio afternoon anchor and A2A founder Jeff Bell spotlights Victoria Jackson and the work she and her family are doing to find a cure for…
October 23, 2018 | Beverly Hills, CA — Chugai Pharmaceutical Co. announced positive results from one of its phase III clinical trials of satralizumab (SA237),…
September 25, 2018 | Beverly Hills, CA — The Guthy-Jackson Charitable Foundation (GJCF) congratulates Alexion Pharmaceuticals on their announcement of positive results from the PREVENT…